Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anton Wellstein

Showing results (1-10 of 114) with videos related to

Pageof 12
Sort By:
Frontiers in Oncology|December 26, 2012
ALK receptor activation, ligands and therapeutic targeting in glioblastoma and in other cancersAnton Wellstein
Cancer Research and Treatment|September 23, 2009
Tumor angiogenesis: initiation and targeting - therapeutic targeting of an FGF-binding protein, an angiogenic switch molecule, and indicator of early stages of gastrointestinal adenocarcinomas -Elena Tassi, Anton Wellstein
Seminars in Oncology|December 21, 2006
The angiogenic switch molecule, secreted FGF-binding protein, an indicator of early stages of pancreatic and colorectal adenocarcinomaElena Tassi, Anton Wellstein
Nature Medicine|March 9, 2011
Hunting ALK to feed targeted cancer therapyAnton Wellstein, Jeffrey A Toretsky
Future Oncology (London, England)|November 13, 2015
Cell density regulates cancer metastasis via the Hippo pathwayGhada M Sharif, Anton Wellstein
JACC. Heart Failure|February 8, 2018
Left Ventricular Dysfunction in Cancer Treatment: Is it Relevant?Benjamin Kenigsberg, Anton Wellstein, Ana Barac
Molecular Pharmacology|January 27, 2004
Systemic morphine administration suppresses genes involved in antigen presentationKaren Beagles, Anton Wellstein, Barbara Bayer
Breast Cancer Research and Treatment|March 5, 2004
Altered Rho GTPase signaling pathways in breast cancer cellsPeter Burbelo, Anton Wellstein, Richard G Pestell
Computational and Structural Biotechnology Journal|July 1, 2016
Circulating biomarkers to monitor cancer progression and treatmentSuthee Rapisuwon, Eveline E Vietsch, Anton Wellstein
The Journal of Biological Chemistry|July 11, 2002
Anti-apoptotic signaling of pleiotrophin through its receptor, anaplastic lymphoma kinaseEmma T Bowden, Gerald E Stoica, Anton Wellstein
Pageof 12

Showing results (1-10 of 114) with videos related to

Sort By:
Pageof 12
Frontiers in Oncology|December 26, 2012
ALK receptor activation, ligands and therapeutic targeting in glioblastoma and in other cancersAnton Wellstein
Cancer Research and Treatment|September 23, 2009
Tumor angiogenesis: initiation and targeting - therapeutic targeting of an FGF-binding protein, an angiogenic switch molecule, and indicator of early stages of gastrointestinal adenocarcinomas -Elena Tassi, Anton Wellstein
Seminars in Oncology|December 21, 2006
The angiogenic switch molecule, secreted FGF-binding protein, an indicator of early stages of pancreatic and colorectal adenocarcinomaElena Tassi, Anton Wellstein
Nature Medicine|March 9, 2011
Hunting ALK to feed targeted cancer therapyAnton Wellstein, Jeffrey A Toretsky
Future Oncology (London, England)|November 13, 2015
Cell density regulates cancer metastasis via the Hippo pathwayGhada M Sharif, Anton Wellstein
JACC. Heart Failure|February 8, 2018
Left Ventricular Dysfunction in Cancer Treatment: Is it Relevant?Benjamin Kenigsberg, Anton Wellstein, Ana Barac
Molecular Pharmacology|January 27, 2004
Systemic morphine administration suppresses genes involved in antigen presentationKaren Beagles, Anton Wellstein, Barbara Bayer
Breast Cancer Research and Treatment|March 5, 2004
Altered Rho GTPase signaling pathways in breast cancer cellsPeter Burbelo, Anton Wellstein, Richard G Pestell
Computational and Structural Biotechnology Journal|July 1, 2016
Circulating biomarkers to monitor cancer progression and treatmentSuthee Rapisuwon, Eveline E Vietsch, Anton Wellstein
The Journal of Biological Chemistry|July 11, 2002
Anti-apoptotic signaling of pleiotrophin through its receptor, anaplastic lymphoma kinaseEmma T Bowden, Gerald E Stoica, Anton Wellstein
Pageof 12